2024-10-17 - Analysis Report
## Cigna Group (CI) Stock Analysis Report

**Company Overview:** Cigna Group is a global health services company providing health insurance, pharmacy benefits, and other related services.

**Performance Analysis:**

**1.  Return Rate vs. S&P 500 (VOO):**

* **Cumulative Return:**  CI: 155.24%, VOO: 135.94%
* **Relative Outperformance:**  19.3%
* **Relative Outperformance Rank (historical):** 46.2% (meaning CI's current outperformance is at the 46.2% percentile compared to its historical outperformance vs. VOO)

**2.  Recent Price Movement:**

* **Closing Price:** $348.84
* **5-Day Moving Average:** $349.3
* **20-Day Moving Average:** $348.32
* **60-Day Moving Average:** $347.65

**3.  Technical Indicators:**

* **RSI:** 49.97 (neutral)
* **PPO:** 0.12 (slightly bullish)
* **Delta_Previous_Relative_Divergence:** -9.58 (indicates a short-term downward trend)
* **Expected Return:** 4.11% (over 5 years, compared to VOO)

**4.  Recent Earnings and Outlook:**

| Date       | EPS   | Revenue        |
| ---------- | ----- | --------------- |
| 2024-08-01 | 5.51  | $60.52 B      |
| 2024-05-02 | -0.97 | $57.26 B      |
| 2023-11-02 | 4.79  | $49.05 B      |
| 2023-08-03 | 4.96  | $48.59 B      |
| 2023-08-01 | 4.96  | $48.59 B      |

* **Latest Earnings:** Q2 2024 EPS of $5.51 beat analyst estimates of $5.34, while revenue of $60.52 B also exceeded expectations of $60.18 B. 

**5.  News and Recent Issues:**

* **Recent Market Outlook:** The recent market outlook for CI is positive. Analysts are generally bullish on Cigna's growth prospects, citing its strong market position, expanding international presence, and increasing focus on value-based care.
* **Analyst Opinions and Performance Highlights:**  Most analysts have a “Buy” or “Strong Buy” rating for Cigna stock, citing factors like its strong earnings growth, increasing market share, and potential for further growth in the healthcare sector.  
* **Industry-Specific News:** Cigna is a player in the highly competitive and evolving healthcare industry. Keep an eye out for news regarding regulatory changes, new healthcare policies, and competitive trends in the market.

**6.  Overall Analysis:**

Cigna Group (CI) shows positive signs of growth and outperformance relative to the S&P 500. While short-term technical indicators suggest a slight downward trend, the strong recent earnings performance and positive analyst sentiment suggest a bullish outlook for the company. 

**7.  Key Takeaways:**

* CI has consistently outperformed the S&P 500 over the long term.
* Strong recent earnings and positive analyst sentiment suggest a bullish outlook.
* Despite recent short-term downward trends, the company's long-term growth potential remains strong.

**Disclaimer:** This report is for informational purposes only and should not be considered investment advice. Consult with a financial professional before making any investment decisions. 
